Working principles | Legal foundations The CTC operates in accordance with the following legal requirements: Parts 1 and 2 of the European Guidelines on Good Manufacturing Practice (GMP) the law regul

Extended processing Special immune selection / depletion from leukapheresis - TCR-α / β-depletions; from bone marrow - CD34 enrichment, CD3 / CD19 or TCR-α / ß depletions; from lymphapheresis - CD25 d

GMP process development We advise and support you in the development of GMP-compliant processes for the production of cell or tissue preparations, also in cooperation with the MHH Presidium's Office f

Services We manufacture medicines that are custom-designed for the patients and their serious medical conditions, especially those of the hematopoietic system. Preparations of the CTC contain function

HOPAN Survey and analysis of regional hospice and palliative care networks using an adapted quality assessment tool Background Hospice work and palliative care are characterized by the cooperation of

OrkA Orofaciopharyngeal and linguistic-communicative activation in old age Background Those who lose the ability to speak and eat are also restricted in their social participation and thus their quali

Completed research projects Understanding the needs of older patients with severe heart failure Needs and perspectives of people at the end of life and their relatives: Example of incurable lung disea

SPICT Identification of patients with palliative care needs in hospitals and practices Copyright: Christian Wyrwa /Institute ofGeneral Medicine and Palliative Medicine/MHH Background Patients with chr

VR-TALKS Virtual Reality Communication Tool for Application and Evaluation with Key Stakeholders and Students Background Delivering bad news is an unavoidable and yet very difficult challenge for phys